Melanotan II, explained.
Research, safety questions, and treatment context.
The form
Pharmacy catalog form
The routine
No established safe cosmetic tanning schedule can be drawn from this pilot.
The evidence
Very small early human studies
Forms listed in a June 2025 catalog. Current availability and individual instructions need confirmation.
On this page
A linked source is not a clinical endorsement. How we handle review and corrections.
- Legal status
- Awaiting FDA review
Came off the FDA's restricted list in April 2026 only because its nomination was withdrawn. An FDA review is due by February 2027.
- At Goodmorrow
- Not offered
What it is
Melanotan II is a synthetic version of alpha-MSH, the hormone that darkens skin. PT-141 (bremelanotide) was developed from it.
What the evidence shows
It does darken skin. It also causes nausea, flushing and unwanted erections, and dermatologists have reported new or changing moles in people who use it.
How Goodmorrow handles it
Not offered, and we don't expect that to change.
Questions people ask
Is Melanotan II legal now that it's off the restricted list?
No. Coming off the restricted list didn't put it on the allowed list. The FDA plans to review it before the end of February 2027.
Sources
- Secondary sourceFDA Peptide Update 2026: Removal from the Do Not Compound List Frier Levitt, August 2026
- Secondary sourceThe US Peptide Status Index Peptide America
Good days ahead.
Join the opening list for appointment updates.